Skip to content

BIRTH: Prospective analysis of BNP-Levels in recompensation therapy in heart failure

BIRTH: Prospective analysis of BNP-Levels in recompensation therapy in heart failure - BIRTH

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00000272
Enrollment
100
Registered
2009-12-14
Start date
2004-01-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I50

Interventions

Group 1: Heart failure (HF) was treated following the recommended guidelines as documented in our standard operating procedures (www.charite.de/kardiologie)

Sponsors

Charité - Universitätsmedizin Berlin Campus Virchow-Klinikum Medizinische Klinik m.S. Kardiologie Internistische Notaufnahme
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -Acute congestive heart failure NYHA III-IV

Exclusion criteria

Exclusion criteria: - Acute ST-elevation myocardial infarction - Anemia (Hb < 10 g/dL) - Cardiac surgery within the last 4 weeks - Malignoma - Inability to give written informed consent - Age under 18 years

Design outcomes

Primary

MeasureTime frame
Cardiovascular Death and Re-admission to hospital for acute congestive heart failure, Assessment during telephone follow-up 1 year after index admission to the Emergency Department

Secondary

MeasureTime frame
Death of acute heart failure, Assessment during 1-year telephone follow-up. || Improvement of NYHA classification score, Evaluation by study physician during clinical assessment and questionning in telephone follow-up || Improvement of the patients physical ability. In order to evaluate the patient's physical constitution a 6-min walk test (6MWT) was performed according to Guyatt et al. Patients were asked to walk at a fast pace until exhaustion occurred or for a period of 6 min on a level surface 50 m in length. The total distance walked (in m) during the test was recorded. All tests were administered by one physician who was unaware of the MLHFQ and laboratory data. The 6-min walking test was assessed on the first day after admission, at day 2, 3, 5 and at discharge from the hospital. || Improvement of LV ejection fraction: Transthoracic echocardiography was performed within 24h after admission following international standards with respect to left ventricular function, diameters and valve function. The ejection fraction was determined using the Teichholz-formula on 5 consecutive heart cycles. In case of arrhythmias (predominately atrial fibrillation) ten cycles were analyzed. || Developing of BNP values during the course of standard heart failure therapy: For the BNP analysis, EDTA plasma was frozen at -20C° . BNP levels (in pg/ml) were measured at baseline and in inpatients at days 1, 2, 3 and 5 after admission as well as at discharge. || Score of the Self-assessment of patients quality of life: Minnesota Living with Heart Failure Questionnaire (MLHFQ): To assess quality of life, patients filled in a cross-cultural adaptation of the Minnesota Living with Heart Failure Questionnaire for German-speaking patients. The test ranged between 0 (no disability) and 100 (severe disability). The questionnaire was completed within 24 hours after admission. || Score of self-assessment health status with the SF-36: The SF-36 is currently the most widely used patient self asse

Countries

Germany

Contacts

Public ContactJulia Searle

Charité Universitätsmedizin Berlin Campus Virchow Klinikum Med. Klinik m.S. Kardiologie Internistische Notaufnahme

julia.searle@charite.de(030) 450 553307

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026